3D printed, biodegradable, and biocompatible intraperitoneal implants loaded with folic acid-targeted/pH-sensitive/doxorubicin-loaded hydroxyapatite nanoparticles for systemic treatment of metastatic breast cancer
Open Access
- 11 December 2025
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Abstract
Three-dimensional porous scaffolds with the capability of controlled drug release have gained increasing interest in chemotherapy due to their sustained reKeywords
Funding Information
- Iran National Science Foundation
This publication has 51 references indexed in Scilit:
- 3D bioprinting: current status and trends—a guide to the literature and industrial practiceBio-Design and Manufacturing, 2021
- From Langmuir isotherm to Brunauer–Emmett–Teller isothermAIChE Journal, 2021
- Mesoporous Mg-doped hydroxyapatite nanorods prepared from bio-waste blue mussel shells for implant applicationsCeramics International, 2020
- Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future OutlookAdvanced Materials, 2018
- Development of the foremost light-curable calcium-silicate MTA cement as root-end in oral surgery. Chemical–physical properties, bioactivity and biological behaviorDental Materials, 2011
- Exploring the Factors Affecting the Solubility of Chitosan in WaterMacromolecular Chemistry and Physics, 2010
- Targeting of Nanoparticles: Folate Receptor2010
- Polymer Implants for Intratumoral Drug Delivery and Cancer TherapyJournal of Pharmaceutical Sciences, 2008
- Mouse 4T1 Breast Tumor ModelCurrent Protocols in Immunology, 2000
- Tissue reaction to intraperitoneal polymer implants: Species difference and effects of corticoid and doxorubicinJournal of Biomedical Materials Research, 1989